Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers.
Bartik, M M
Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers. [electronic resource] - Cancer immunology, immunotherapy : CII 1991 - 79-89 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0340-7004
10.1007/BF01741340 doi
Animals
CD4-CD8 Ratio
CD8 Antigens--analysis
Cytotoxicity, Immunologic--drug effects
Female
Interleukin-2--pharmacology
Lymphocyte Activation
Melphalan--administration & dosage
Mice
Mice, Inbred BALB C
Plasmacytoma--drug therapy
Recombinant Proteins--pharmacology
T-Lymphocyte Subsets--drug effects
Thymoma--immunology
Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers. [electronic resource] - Cancer immunology, immunotherapy : CII 1991 - 79-89 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0340-7004
10.1007/BF01741340 doi
Animals
CD4-CD8 Ratio
CD8 Antigens--analysis
Cytotoxicity, Immunologic--drug effects
Female
Interleukin-2--pharmacology
Lymphocyte Activation
Melphalan--administration & dosage
Mice
Mice, Inbred BALB C
Plasmacytoma--drug therapy
Recombinant Proteins--pharmacology
T-Lymphocyte Subsets--drug effects
Thymoma--immunology